tenofovir has been researched along with Leanness in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ake, JA; Bahemana, E; Cavanaugh, JS; Crowell, TA; Dear, N; Esber, AL; Ganesan, K; Iroezindu, M; Kibuuka, H; Maswai, J; Mwesigwa, R; Owuoth, J; Parikh, AP; Polyak, CS; Reed, D; Shah, N; Singoei, V | 1 |
| Isoda, A; Matsumoto, M; Mihara, M; Sawamura, M | 1 |
| Chawana, TD; Ngara, B; Nhachi, CFB; Rusakaniko, S; Zvada, S | 1 |
| Gatanaga, H; Genka, I; Honda, M; Kikuchi, Y; Kimura, S; Oka, S; Tachikawa, N; Tanuma, J; Teruya, K; Ueda, A; Yazaki, H | 1 |
1 trial(s) available for tenofovir and Leanness
| Article | Year |
|---|---|
Pharmacokinetic-pharmacodynamic modelling of atazanavir in hair among adolescents on antiretroviral treatment in Zimbabwe.
Topics: Adolescent; Anti-Retroviral Agents; Atazanavir Sulfate; Caregivers; Female; Hair; HIV Infections; Humans; Lamivudine; Male; Medication Adherence; Models, Biological; Overweight; Ritonavir; Tenofovir; Thinness; Viral Load; Zimbabwe | 2021 |
3 other study(ies) available for tenofovir and Leanness
| Article | Year |
|---|---|
Epidemiology of Tuberculosis Among People Living With HIV in the African Cohort Study From 2013 to 2021.
Topics: CD4 Lymphocyte Count; Cohort Studies; HIV Infections; Humans; Incidence; Lamivudine; Risk Factors; Tenofovir; Thinness; Tuberculosis | 2023 |
Severe lactic acidosis during tenofovir disoproxil fumarate and cobicistat combination for HIV patient.
Topics: Acidosis, Lactic; Adenine; Anti-HIV Agents; Cobicistat; Drug Combinations; Female; HIV Infections; Humans; Middle Aged; Tenofovir; Thinness; Treatment Outcome | 2023 |
Urinary beta2-microglobulin as a possible sensitive marker for renal injury caused by tenofovir disoproxil fumarate.
Topics: Adenine; Adult; Anti-HIV Agents; beta 2-Microglobulin; Biomarkers; Creatinine; Female; HIV Infections; HIV-1; Humans; Kidney Tubules; Lopinavir; Male; Middle Aged; Organophosphonates; Pyrimidinones; Tenofovir; Thinness | 2006 |